Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Roop

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Differentiation; Research in Biological Diversity|December 1, 1996
A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosisJ R Bickenbach, M A Longley, D S Bundman, et al.
Prenatal Diagnosis|September 22, 1998
Prenatal diagnosis for keratin mutations to exclude transmission of epidermolytic hyperkeratosisJ A Rothnagel, M T Lin, M A Longley, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Structural and functional implications of amino acid sequences of keratin intermediate filament subunitsP M Steinert, W W Idler, X M Zhou, et al.
The Journal of Investigative Dermatology|April 14, 1999
A novel substitution in keratin 10 in epidermolytic hyperkeratosisM J Arin, M A Longley, I Anton-Lamprecht, et al.
Nature Genetics|August 1, 1994
Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of SiemensJ A Rothnagel, H Traupe, S Wojcik, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibitionX J Wang, D A Greenhalgh, J R Bickenbach, et al.
Immunogenetics|January 1, 1987
Assignment of the Ly-6--Ril-1--Sis--H-30--Pol-5/Xmmv-72--Ins-3--Krt-1--Int-1 --Gdc-1 region to mouse chromosome 15D Meruelo, A Rossomando, S Scandalis, et al.
The Journal of Cell Biology|October 19, 2000
Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratodermaY Suga, M Jarnik, P S Attar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1984
The complete cDNA and deduced amino acid sequence of a type II mouse epidermal keratin of 60,000 Da: analysis of sequence differences between type I and type II keratinsP M Steinert, D A Parry, E L Racoosin, et al.
Nature|October 5, 1986
An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissueD R Roop, D R Lowy, P E Tambourin, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Differentiation; Research in Biological Diversity|December 1, 1996
A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosisJ R Bickenbach, M A Longley, D S Bundman, et al.
Prenatal Diagnosis|September 22, 1998
Prenatal diagnosis for keratin mutations to exclude transmission of epidermolytic hyperkeratosisJ A Rothnagel, M T Lin, M A Longley, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Structural and functional implications of amino acid sequences of keratin intermediate filament subunitsP M Steinert, W W Idler, X M Zhou, et al.
The Journal of Investigative Dermatology|April 14, 1999
A novel substitution in keratin 10 in epidermolytic hyperkeratosisM J Arin, M A Longley, I Anton-Lamprecht, et al.
Nature Genetics|August 1, 1994
Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of SiemensJ A Rothnagel, H Traupe, S Wojcik, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibitionX J Wang, D A Greenhalgh, J R Bickenbach, et al.
Immunogenetics|January 1, 1987
Assignment of the Ly-6--Ril-1--Sis--H-30--Pol-5/Xmmv-72--Ins-3--Krt-1--Int-1 --Gdc-1 region to mouse chromosome 15D Meruelo, A Rossomando, S Scandalis, et al.
The Journal of Cell Biology|October 19, 2000
Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratodermaY Suga, M Jarnik, P S Attar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1984
The complete cDNA and deduced amino acid sequence of a type II mouse epidermal keratin of 60,000 Da: analysis of sequence differences between type I and type II keratinsP M Steinert, D A Parry, E L Racoosin, et al.
Nature|October 5, 1986
An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissueD R Roop, D R Lowy, P E Tambourin, et al.
Pageof 16